|
Volumn 21, Issue 1, 2006, Pages 236-237
|
Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy [8]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIBIOTIC AGENT;
CASPOFUNGIN;
CEFUROXIME;
CIPROFLOXACIN;
FLUCONAZOLE;
PYRROLE DERIVATIVE;
TOBRAMYCIN;
ABDOMINAL DISTENSION;
ABDOMINAL PAIN;
AGED;
CANDIDA ALBICANS;
CANDIDIASIS;
CASE REPORT;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
DIFFERENTIAL DIAGNOSIS;
DRUG RESISTANCE;
DRUG SENSITIVITY;
DYSURIA;
FEVER;
FUNGUS ISOLATION;
HUMAN;
HYPOTENSION;
LETTER;
LEUKOCYTOSIS;
MALE;
MYCOSIS;
NONHUMAN;
PERITONEAL DIALYSIS;
PERITONEAL FLUID;
PERITONITIS;
PRIORITY JOURNAL;
PYELONEPHRITIS;
PYURIA;
SIDE EFFECT;
URINALYSIS;
URINARY TRACT INFECTION;
URINE CULTURE;
AGED;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
CANDIDA ALBICANS;
CANDIDIASIS;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MALE;
PEPTIDES, CYCLIC;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
PERITONITIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 30344477950
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfi162 Document Type: Letter |
Times cited : (25)
|
References (5)
|